Log In
Print
BCIQ
Print
Print this Print this
 

CDX-301

  Manage Alerts
Collapse Summary General Information
Company Amgen Inc.
DescriptionFMS-like tyrosine kinase 3 ligand (FLT3LG) that is a growth factor for dendritic cells
Molecular Target FMS-like tyrosine kinase 3 ligand (FLT3LG)
Mechanism of ActionImmune modulation
Latest Stage of DevelopmentPhase I/II
IndicationTransplant
Partner

Celldex Therapeutics Inc.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today